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LONG-TERM EFFECTIVENESS OF COMBINED ALPRAZOLAM AND 
COGNITIVE-BEHAVIORAL THERAPIES IN PANIC DISORDER 
Steven M. Bond, Department of Psychology, IWU and 
Timothy J. Bruce', Department of Psychiahy, UICOMP 
Benzodiazepines, particularly alprazolam, have been shown to be effective in 
the treatment of panic disorder. However, dif ficult withdrawal and high relapse 
rates after successful discontinuation continue to be problems with this class of 
medication. Recent studies instituting cognitive-behavioral therapy as a treatment 
supplement to alprazolam taper have shown promising results at short-term 
follow-up. The present study investigated whether these procedures produce long­
term (two- to four-year) improvement. Patients were stabilized on alprazolam and 
randomly assigned to either an alprazolam-only group or the same condition with 
twelve weeks of concurrent cognitive-behavioral therapy. Twenty patients who 
completed these treatments were assessed at two- to four-year follow-up. In addition 
to the discontinuation success rates, self-report and clinician-rated measures 
concerning panic attack frequency, disability intensity, agoraphobic avoidance, and 
anxiety severity were used to evaluate relapse. Preliminary analysis of clinician­
rated assessments suggests that patients receiving combined therapy were clinically 
improved at long-term f ollow-up in comparable percentages to previously 
published data. Results and clinical implications for combined alprazolam and 
cognitive-behavioral therapy will be discussed at the conference. 
